About iNTD and How It Can Benefit Patients With AADC Deficiency

About iNTD and How It Can Benefit Patients With AADC Deficiency

287725

About iNTD and How It Can Benefit Patients With AADC Deficiency

The International Working Group on Neurotransmitter Related Disorders, known as iNTD, is an organization that seeks to raise awareness and improve the treatment of rare neurological conditions, including aromatic l-amino acid decarboxylase (AADC) deficiency. Here is more information about the iNTD. You can learn about its goals, and how its work can help people with AADC deficiency. What is the iNTD? The iNTD was founded in 2013 with the aim of improving the care provided…

You must be logged in to read/download the full post.